Andrew Beck is CEO and Co-founder of PathAI. PathAI's mission is to improve patient outcomes with AI-powered pathology. The platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.